Antibody Therapeutics for Life


2019 China BioMed Innovation and Investment Conference
  • Written by PharmAbcine
  • Written date 2019-09-21 13:35:16
  • Inquire 2429
Attachments 2019 International Innovative Oncology Companies Roadshow Showcase (0910).pptx

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo,

Chairman and CEO of PharmAbcine and Dr. Hyunsun Park, CBO/COO are attending to "2019 China 

BioMed Innovation and Investment Conference" in Suzhou, China on September 21-23 to have 1:1 

partnering meetings. Dr. Jin-San Yoo will present PharmAbcine R&D progress at "International 

Innovative Oncology Companies Roadshow" on September 22, 2019. 

Please check the attached file for details.


Prev 2019 Scripps Korea Society Symposium
Next PharmAbcine, 20th EDQM MAB Working Party